-
Mashup Score: 0Wolters Kluwer Health - 2 year(s) ago
JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers: Internet Explorer From the Tools menu, select Options Click the Content tab Select Enable…
Source: lww.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Wolters Kluwer Health - 2 year(s) ago
JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers: Internet Explorer From the Tools menu, select Options Click the Content tab Select Enable…
Source: lww.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
3 QUESTIONS ON... A New Target Protein in #MetastaticProstateCancer With Wei Yang, PhD, Associate Professor of Surgery & Biomedical Sciences at @CSCancerCare: https://t.co/tHE3ukeXiH #prostatecancer https://t.co/fYXyoVTw7d
-
-
Mashup Score: 1
Metabolic syndrome and its pharmacologic treatment can potentially influence the progression of prostate cancer in men receiving androgen deprivation therapy (ADT). We aimed to evaluate the association between metabolic syndrome and its pharmacologic treatment with time to castration-resistant prostate cancer (CRPC). We identified 409 men with metastatic castration-sensitive prostate cancer…
Source: NatureCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Check our new article on MetS and CRPC by Geng et al @kibelas @loreleimucci #Metabolic #metastaticprostatecancer https://t.co/BIBzmaX2WP https://t.co/IKFllak38N
-
-
Mashup Score: 2Samuel R. Denmeade, MD @hopkinskimmel #ASCOPubs #Metast - 3 year(s) ago
Samuel R. Denmeade, MD of The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins discusses TRANSFORMER: A Randomized Phase II Study Comparing Bipol
Source: www.oncologytube.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
TRANSFORMER: A Randomized Phase II Study - Prostate Cancer Samuel R. Denmeade, MD @hopkinskimmel #ASCOPubs #MetastaticProstateCancer #ProstateCancer #Cancer #Research Link To FULL Video: https://t.co/pLY1WXUiIF https://t.co/xLX2CaXmqp
-
-
Mashup Score: 0Prognostic Value of Germline DNA Repair Gene Mutations in De Novo Metastatic and Castration‐Sensitive Prostate Cancer - 4 year(s) ago
There is increasing interest in defining the role of germline DNA damage repair gene mutations (gDDRm) in de novo metastatic castration sensitive prostate cancer (mCSPC) cases to potentially guide th…
Source: The OncologistCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Prognostic Value of Germline DNA Repair Gene Mutations in De Novo Metastatic and Castration‐Sensitive Prostate Cancer #MetastaticProstateCancer #mPCa #mCRPC #GermlineMutations #DNARepairGenes #BRCA2 #PrognosticValue #gDDRm https://t.co/HwAztwSjsT https://t.co/QtBVoMdGYk
-
3 QUESTIONS ON... A New Target Protein in #MetastaticProstateCancer With Wei Yang, PhD, Associate Professor of Surgery & Biomedical Sciences at @CSCancerCare: https://t.co/iOGamCzidY #prostatecancer https://t.co/xEK1sfcZax